[1]Butler;Nordin;L'Italien;Zweisler;Poschel;Marriott[JournalofMedicinalChemistry,1984,vol.27,#5,p.684-691]
[2]CurrentPatentAssignee:PFIZERINC-US4145347,1979,A
100-76-5
1001353-92-9
100911-49-7
1157849-50-7
123536-15-2
1236348-35-8
5468-23-5 | DIETHYL ACETOXYMALONATE | AA00D9IP | MFCD00039895
52773-66-7 | Z-O-Benzyl-l-tyrosine hydroxysuccinimide ester | AA00D9PX | MFCD00158646
450409-87-7 | 3,5-BIS(TRIFLUOROMETHYL)PHENYLSULFONYLETHANOL | AA00D9VY | MFCD03789228
51094-78-1 | TANTALUM(V) BUTOXIDE | AA00DA2J | MFCD00078035
501925-31-1 | PNU-120596 | AA00DA8P | MFCD00095313
53312-79-1 | 3-Amino-4-chlorobenzonitrile | AA00DAB4 | MFCD00017089
43088-92-2 | 1,2,4-TRIAZOLE-D3 | AA00DAIF | MFCD11501551
543713-43-5 | 1-(3-Pyridin-3-ylisoxazol-5-yl)methanamine | AA00DAOD | MFCD08059814
431884-69-4 | N,N-Dimethyl-4-(piperazin-1-ylcarbonothioyl)aniline | AA00DASF | MFCD03140172
503070-57-3 | 2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene | AA00DB0H | MFCD21337362